US Broker Ratings

Eli Lilly and Company (LLY) Stock Analysis: A Robust 12.28% Upside Potential in the Healthcare Sector

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its promising growth metrics and strategic initiatives. With..

AngioDynamics, Inc. (ANGO) Investor Outlook: Unpacking the 30.89% Potential Upside

For investors keen on exploring opportunities within the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling case with a notable potential upside of 30.89%. This..

Kamada Ltd. (KMDA) Stock Analysis: Exploring 52.89% Potential Upside Amid Robust Revenue Growth

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector specializing in plasma-derived protein therapeutics, has been making waves with its impressive financial metrics and..

Oruka Therapeutics, Inc. (ORKA): Analyst Consensus Highlights 81% Potential Upside

Oruka Therapeutics, Inc. (ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, is garnering significant attention from investors focused on high-growth opportunities in the biotechnology..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a 42% Potential Upside Amidst Biotech Innovation

Investors are increasingly turning their attention to Septerna, Inc. (NASDAQ: SEPN), a burgeoning player in the biotechnology sector, driven by its promising potential upside and cutting-edge..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unpacking a Promising 113.73% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out in the biotechnology sector with a market capitalization of approximately $993.64 million. This clinical-stage biopharmaceutical company, headquartered in Cambridge,..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring an 81.7% Potential Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $291.69 million, this..

Sonida Senior Living, Inc. (SNDA): Investor Outlook Reveals 31.82% Potential Upside in Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector specializing in senior housing communities, presents a compelling opportunity for investors seeking growth in..

Celcuity Inc. (CELC) Stock Analysis: Exploring a Promising 102% Potential Upside in Biotechnology

For investors with a keen interest in the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents a compelling opportunity. This clinical-stage biotech firm, headquartered in Minneapolis, is..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth with Strategic Collaborations in the Healthcare Sector

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector’s diagnostics and research industry, has been making waves with its innovative approach to cancer genomic..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 87.99% Upside for Biotech Investors

Precigen, Inc. (PGEN), a trailblazing biopharmaceutical entity headquartered in Germantown, Maryland, is capturing investor attention with its ambitious focus on gene and cell therapies targeted at..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 20% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) stands as a prominent player in the healthcare sector, particularly within the specialized niche of medical devices for pediatric orthopedic conditions. With..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Data Leader Eyes 96% Potential Upside

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare sector, specializes in data analytics and technology-enabled cost management solutions. With a market capitalization of $395.89..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Navigating a Stable Path with Strategic Collaborations

Theravance Biopharma, Inc. (NASDAQ: TBPH), a key player in the biotechnology sector, continues to attract attention from investors due to its strategic collaborations and innovative product..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 217.68% Potential Upside in the Biotech Sector

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology realm, is capturing the attention of investors with its notable potential upside of 217.68%. Headquartered..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising 85.88% Potential Upside Ignites Investor Interest

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a burgeoning force in the biotechnology sector, is capturing the spotlight with its focus on pioneering treatments for central nervous system..

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech Gem with 71% Upside Potential

AnaptysBio, Inc. (NASDAQ: ANAB) presents a compelling opportunity for investors in the biotechnology sector, bolstered by robust analyst ratings and a promising pipeline of therapeutic innovations...

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unpacking the 21% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands as a compelling player in the healthcare sector, specifically within the niche of medical devices. With a market capitalization..

Ginkgo Bioworks Holdings (DNA): Investor Outlook on the Biotech Innovator with a Potential 31.71% Downside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a pioneering force within the biotechnology sector, offering a comprehensive platform for cell engineering that spans multiple industries,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds